Join us in London on 30th September 2025 to recognise and celebrate industry excellence at the Precision Medicine Awards 2025, taking place after the first day of our Biomarkers & Precision Medicine 2025 event.
Precision Medicine is reshaping how we understand, treat, and manage disease. At the core of this transformation are people and projects driving better patient outcomes through tailored, targeted, and data-driven interventions. Our Precision Medicine Awards 2025 event recognises standout achievements across the global personalised healthcare ecosystem, from translational research breakthroughs to patient-centric innovations - setting a definitive benchmark for excellence in the field of personalised healthcare.
Precision Medicine is the recognised platform for your R&D community, and with over 20 years’ experience hosting conferences and awards - our awards recognise innovators across a global community of more than 40,000 specialists. This year’s awards spotlight 13 categories, chosen to reflect the global personalised healthcare ecosystem - including AI innovation, biomarker development, diagnostic breakthroughs, industry-academic collaborations, and excellence in patient-centric and rare disease precision medicine.
Congratulations to all our shortlisted entrants for this year's awards - representing pharmaceutical companies, diagnostics leaders, start-ups, academic institutions, and multi-stakeholder collaborations - each bringing unique contributions to the table. Shortlisted nominees include Altum Sequencing, Cancer Research UK, IXICO, Johnson & Johnson, Nordic Bioscience, the Precision Cancer Consortium, PriveBio Therapeutics, and Roche Diagnostics Solutions. Each has demonstrated visionary impact in their respective categories, from AI-powered analytics to breakthrough collaborations and tools for liver fibrosis, neurodegeneration, oncology and more. Visit our awards website for the full list of shortlisted nominees.
Check out some of our exclusive interviews with award nominees, offering deeper insights into their work and future vision. Featured conversations with Altum Sequencing, the Precision Cancer Consortium, Marshall Porterfield (GeneLab Open Science program at NASA), and Viola Heinzelmann-Schwarz (Swiss Tumour Profiler study) offer a window into how innovation is translating into clinical value around the world.
The awards ceremony also provides a rare moment to reflect on progress made across personalised medicine. Outstanding Contribution to Precision Medicine nominees such as Bruce Jordan (Roche Diagnostics), Leonard Lipovich (Wayne State University), and Philippe Pinton (Ferring Pharmaceuticals) exemplify long-term commitment to driving the field forward. Meanwhile, categories like the Omics Data Visionary Award and Champion of Tailored Therapies for Oncology underscore the importance of data integration and personalised oncology solutions in accelerating clinical translation.
This year’s independent judging panel brings together industry pioneers, R&D veterans, and biotech leaders - including senior leaders from AstraZeneca, Novo Nordisk, Roche, Lundbeck and ARCHIMED.
Laurent Audoly – CEO & Co-Founder, PriveBio
Richard Barker – Chair, Metadvice & New Medicine Partners
Michael Cannarile – Head of Oncology Biomarkers, Roche
Peter Groenen – GM, Alpinuity Bio & Head of Translational Science, cerebrumDAO
Adama Ibrahim – VP Digital Transformation, R&D, Novo Nordisk
Keith James – SVP Drug Discovery (Retired), insitro
Indra Joshi – Board Advisor, Upliift
Morten Karsdal – CEO, Nordic Biosciences
Johan Luthman – EVP & Head of R&D, Lundbeck
Patricia McLoughlin – Senior Director Business Development, Aerogen
Maria Orr – Head of Precision Medicine, AstraZeneca
Miro Venturi – Operating Partner, ARCHIMED
Beyond recognition, our awards event offers strategic value and tangible benefits to participants. Join an exclusive group of 200 leaders for an evening of celebration and high-impact networking. From honouring the top innovations of the year to connecting with new collaborators and potential partners, the event brings together a curated mix of scientific minds, technical experts, and commercial visionaries.
Be recognised: Highlight your company among the top innovators earning recognition from industry peers.
Be seen: Connect with a curated network of leading organisations and influential figures attending both the Awards and the concurrent conference.
Be inspired: Give your team a reason to celebrate and re-energise your mission with a bold vision for the future of healthcare and honour the major accomplishments and advancements in precision medicine over the past year.
For the broader Precision Medicine community, the Awards serve another crucial purpose - fostering a culture of excellence. By celebrating what works, recognising emerging trends, and elevating new voices, the event fuels the collective ambition to push boundaries and drive better patient outcomes.
As the personalised healthcare sector continues to grow - transforming one-size-fits-all medicine into targeted, effective treatments - events like this unite the community around a shared purpose. Recognising success is essential to sustaining momentum, and our awards champion impact, leadership, and a vision for healthcare where every patient gets the right treatment at the right time.
Register now to join us on 30th September 2025 at the prestigious Church House Assembly Hall in Westminster, for an evening that not only celebrates success but inspires the next chapter of progress in personalised healthcare.
Celebrate your industry. Acknowledge your impact. Accelerate better patient outcomes.